Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients will undergo a combined rehabilitation treatment consisting of 15 sessions on Lokomat and 15 sessions of physical therapy over three weeks for a total of 30 sessions. Two sessions/day for 5 days a week. The same subjects will conduct clinical-functional assessments before, at the end of treatment, and after a 3-month follow-up:
3D Gait Analysis with defined protocol (BTSBioenginner); Spastic Paraplegia Rating Scale (SPRS); Six-Minute Walk Test (6MWT), Ten Meters Walk Test (10MWT), Gross Motor Function Measure-88 (GMFM-88) and Berg Balance Scale (BBS); Quality of life questionnaires: Medical Outcome Survey Short Form (SF-36) and ad hoc questionnaire for subjective assessment of symptoms during walking (HSP-SNAP).
This study is part of normal clinical practice and does not involve any changes to the current rehabilitation course for patients.
In the field of rare neurological diseases, familiar spastic paraplegia represents a movement disorder with no specific therapy that can treat the disease or stop its evolution. Therefore, "therapy" is mainly symptomatic, going to act not on the cause of the disorder but on its clinical manifestation. In this context, the definition of effective rehabilitative treatment protocols is extremely important to ensure a qualitatively consistent intake with the goal of containing the functional decline related to the natural history of pathology. The crucial aspect of the disease is represented by alterations in gait pattern resulting in reduced functional skills and negative impact on the subject's quality of life.
Over the past 20 years, robotic technological gait rehabilitation has entered and spread in addition to conventional rehabilitation because of its ability to be highly motivating and engaging, showing itself effective as a complementary therapy. Among the various systems on the market, Lokomat (HOCOMA) is one of the most popular and widely used for treatment in both pediatric and adult populations. The literature is full with works in which Lokomat is used in subjects with neurological disorders (Stroke, Spinal Cord Injury, Infantile Cerebral Palsy) with good results especially in the functional domain. The objective of our study is to evaluate the efficacyof an intensive rehabilitation protocol with Lokomat combined with traditional treatment in a mixed population (pediatric and adult) of subjects with hereditary spastic paraplegia. In addition, follow-up evaluation will allow consideration of the maintenance of the results obtained from the intensive course.
Patients undergo a combined rehabilitation treatment consisting of 15 sessions on Lokomat and 15 sessions of physical therapy over three weeks for a total of 30 sessions. The same subjects undergo clinical-functional evaluations before, at the end of treatment and after a 3-month follow-up:
3D Gait Analysis with defined protocol (BTSBioenginner); Spastic Paraplegia Rating Scale (SPRS); Six-Minute Walk Test (6MWT), Ten Meters Walk Test (10MWT), Gross Motor Function Measure-88 (GMFM-88) and Berg Balance Scale (BBS); Quality of life questionnaires: Medical Outcome Survey Short Form (SF-36) and ad hoc questionnaire for subjective assessment of symptoms during walking (HSP-SNAP).
The proposed study is both retrospective and prospective: 29 subjects have already been included in the retrospective database, and it is hypothesized to collect data from an additional 21 subjects.
The treatment will be able to take place in both inpatient and MAC settings, and the protocol includes performance evaluation through clinical and instrumental assessments in the population of subjects with HSP treated with the Lokomat device at the IRCCS Medea site in Bosisio Parini.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hereditary Spastic Paraplegia (HSP) | Patients undergo a combined rehabilitation treatment consisting of 15 sessions on Lokomat and 15 sessions of physical therapy over three weeks for a total of 30 sessions. The same subjects undergo clinical-functional evaluations before, at the end of treatment and after a 3-month follow-up. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Robot-Assisted Gait Training | Device | 15 sessions of robot-assisted gait training(LOKOMAT)+ 15 session of usual treatment for a total of 30 sessions in three weeks. 45 minutes for each session. |
| Measure | Description | Time Frame |
|---|---|---|
| Six-Minute Walk Test (6MWT) | Endurance Test | T0(pre-training) |
| Six-Minute Walk Test (6MWT) | Endurance Test | T1(after 3 weeks of training) |
| Six-Minute Walk Test (6MWT) | Endurance Test | T2(3 months after T1) |
| Measure | Description | Time Frame |
|---|---|---|
| Medical Outcome Survey Short Form (SF-36) | Questionnaire Quality of Life. 2 index: physical health and mental health. Higher score better health perception. | T0(pre-training) |
| Hereditary Spastic Paraplegia Self-Notion and Perception (HSP-SNAP) |
| Measure | Description | Time Frame |
|---|---|---|
| 3D GAIT ANALYSIS | Analysis of the gait pattern | T0(pre-training),T1(after 3 weeks of training),T2(3 months after T1) |
| Ten Meters Walk Test (10MWT) | Gait Velocity Test |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients affected by a hereditary spasti paraplegia with or without a genetic diagnosis.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| ELEONORA DIELLA | Contact | 3286859456 | eleonora.diella@lanostrafamiglia.it |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Irccs Eugenio Medea | Recruiting | Bosisio Parini | Italy/lecco | Italy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015419 | Spastic Paraplegia, Hereditary |
| ID | Term |
|---|---|
| D015417 | Hereditary Sensory and Motor Neuropathy |
| D009421 | Nervous System Malformations |
| D009422 | Nervous System Diseases |
| D020271 | Heredodegenerative Disorders, Nervous System |
Not provided
Not provided
Not provided
Not provided
Not provided
Questionnaire Self-Notion and Perception. Scoring: 0-48. Higher score better health.
| T0(pre-training) |
| Spastic Paraplegia Rating Scale (SPRS) | Severity of the HSP. Score: 0-52. Higher score more severity. | T0(pre-training) |
| Medical Outcome Survey Short Form (SF-36) | Questionnaire Quality of Life. 2 index: physical health and mental health. Higher score better health perception. | T1(after 3 weeks of training) |
| Hereditary Spastic Paraplegia Self-Notion and Perception (HSP-SNAP) | Questionnaire Self-Notion and Perception. Scoring: 0-48. Higher score better health. | T1(after 3 weeks of training) |
| Spastic Paraplegia Rating Scale (SPRS) | Severity of the HSP. Score: 0-52. Higher score more severity | T1(after 3 weeks of training) |
| Medical Outcome Survey Short Form (SF-36) | Questionnaire Quality of Life. 2 index: physical health and mental health. Higher score better health perception. | T2(3 months after T1) |
| Hereditary Spastic Paraplegia Self-Notion and Perception (HSP-SNAP) | Questionnaire Self-Notion and Perception. Scoring: 0-48. Higher score better health. | T2(3 months after T1) |
| Spastic Paraplegia Rating Scale (SPRS) | Severity of the HSP. Score: 0-52. Higher score more severity | T2(3 months after T1) |
| T0(pre-training),T1(after 3 weeks of training),T2(3 months after T1) |
| Gross Motor Function Measure-88 (GMFM-88) | Pediatric Gross Motor Evaluation. Score:0-264. Higher score more function. | T0(pre-training),T1(after 3 weeks of training),T2(3 months after T1) |
| Berg Balance Scale (BBS) | Balance Test. Score:0-56. Higher score better balance. | T0(pre-training),T1(after 3 weeks of training),T2(3 months after T1) |
| 3D GAIT ANALYSIS | Analysis of the gait pattern | T1(after 3 weeks of training) |
| Ten Meters Walk Test (10MWT) | Gait Velocity Test | T1(after 3 weeks of training) |
| Gross Motor Function Measure-88 (GMFM-88) | Pediatric Gross Motor Evaluation. Score:0-264. Higher score more function. | T1(after 3 weeks of training) |
| Berg Balance Scale (BBS) | Balance Test. Score:0-56. Higher score better balance. | T1(after 3 weeks of training) |
| 3D GAIT ANALYSIS | Analysis of the gait pattern | T2(3 months after T1) |
| Ten Meters Walk Test (10MWT) | Gait Velocity Test | T2(3 months after T1) |
| Gross Motor Function Measure-88 (GMFM-88) | Pediatric Gross Motor Evaluation. Score:0-264. Higher score more function. | T2(3 months after T1) |
| Berg Balance Scale (BBS) | Balance Test. Score:0-56. Higher score better balance. | T2(3 months after T1) |
| D019636 | Neurodegenerative Diseases |
| D011115 | Polyneuropathies |
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D030342 | Genetic Diseases, Inborn |